Comparison of multiple drug regimens for reduction of synovitis-induced lameness pain in meat-type goats
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.25.04.0134 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Mikaela M Weeder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS. Hauptthemen laut MEDLINE: Lameness, Animal, Meloxicam, Clonixin, Synovitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study evaluated the analgesic effects of firocoxib, meloxicam, and transdermal flunixin in meat-type goats with experimentally induced lameness.
Methods
44 crossbred castrated meat-type goats with an average weight of 35 kg (range, 25 to 43 kg) were enrolled from June to December 2022. Lameness was induced with amphotericin B injected in the distal interphalangeal joint of the left hind lateral claw. After a washout period, lameness was reproduced in the right hind limb. Eleven treatment groups were implemented: firocoxib (0.5, 1.0, and 2.0 mg/kg), meloxicam (1.0, 2.0, and 3.0 mg/kg, transdermal flunixin (3.3, 4.2, and 5.0 mg/kg), and positive and negative control. Outcome measurements included infrared thermography, mechanical nociception threshold, plasma cortisol, plasma substance P, kinetic gait analysis, visual lameness scoring, and visual analog scoring and were collected at –24, 0, 1, 2, 3, 4, 6, 8, 10, 12, 24, 36, 48, 60, and 72 hours relative to lameness induction.
Results
Transdermal flunixin at 3.3 and 5.0 mg/kg demonstrated the greatest analgesic effects from outcome measurements collected.
Conclusions
Transdermal flunixin meglumine provides the most effective analgesia for goats with induced lameness, suggesting it may be the preferred option for pain relief in goats with lameness symptoms. Clinical Relevance Transdermal flunixin meglumine at 3.3 or 5.0 mg/kg provided the best results for pain mitigation in goats with induced lameness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
- Veterinary Education, Research, and Outreach, College of Veterinary and Biomedical Sciences, Texas A&M University, Canyon, TX.
- Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS.
- Department of Animal Sciences, College of Agriculture, Kansas State University, Manhattan, KS.
ORCID-Profile: Mikaela M Weeder, Michael D Kleinhenz, Andrew K Curtis, Johann F Coetzee
Zitieren
APA
Weeder, M. M., Kleinhenz, M. D., Reppert, E. J., Curtis, A. K., Viscardi, A. V., Leslie, A., Bear, M., Fritz, B., Dahmer, P., & Coetzee, J. F. (2025). Comparison of multiple drug regimens for reduction of synovitis-induced lameness pain in meat-type goats. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.04.0134
Vancouver
Weeder MM, Kleinhenz MD, Reppert EJ, Curtis AK, Viscardi AV, Leslie A, et al. Comparison of multiple drug regimens for reduction of synovitis-induced lameness pain in meat-type goats. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.04.0134
BibTeX
@article{Weeder2025,
author = {Weeder, Mikaela M and Kleinhenz, Michael D and Reppert, Emily J and Curtis, Andrew K and Viscardi, Abbie V and Leslie, Ally and Bear, Misty and Fritz, Bailey and Dahmer, Payton and Coetzee, Johann F},
title = {Comparison of multiple drug regimens for reduction of synovitis-induced lameness pain in meat-type goats},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.25.04.0134}
}
EUVIMED